239 related articles for article (PubMed ID: 18041590)
1. Molecular genetic events in gastrointestinal and pancreatic neuroendocrine tumors.
Lubensky IA; Zhuang Z
Endocr Pathol; 2007; 18(3):156-62. PubMed ID: 18041590
[TBL] [Abstract][Full Text] [Related]
2. Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics.
Rindi G; Bordi C
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):519-34. PubMed ID: 16183525
[TBL] [Abstract][Full Text] [Related]
3. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.
Rindi G; Villanacci V; Ubiali A
Digestion; 2000; 62 Suppl 1():19-26. PubMed ID: 10940683
[TBL] [Abstract][Full Text] [Related]
4. Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors).
Oberg K
Curr Opin Endocrinol Diabetes Obes; 2009 Feb; 16(1):72-8. PubMed ID: 19115524
[TBL] [Abstract][Full Text] [Related]
5. Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract.
Rindi G; Candusso ME; Solcia E
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S135-8. PubMed ID: 10604117
[TBL] [Abstract][Full Text] [Related]
6. Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation.
Tönnies H; Toliat MR; Ramel C; Pape UF; Neitzel H; Berger W; Wiedenmann B
Gut; 2001 Apr; 48(4):536-41. PubMed ID: 11247899
[TBL] [Abstract][Full Text] [Related]
7. Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic review.
Girardi DM; Silva ACB; Rêgo JFM; Coudry RA; Riechelmann RP
Cancer Treat Rev; 2017 May; 56():28-35. PubMed ID: 28456055
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.
Asa SL; La Rosa S; Basturk O; Adsay V; Minnetti M; Grossman AB
Endocr Pathol; 2021 Mar; 32(1):169-191. PubMed ID: 33459926
[TBL] [Abstract][Full Text] [Related]
9. MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation.
Fujii T; Kawai T; Saito K; Hishima T; Hayashi Y; Imura J; Hironaka M; Hosoya Y; Koike M; Fukayama M
Pathol Int; 1999 Nov; 49(11):968-73. PubMed ID: 10594843
[TBL] [Abstract][Full Text] [Related]
10. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology.
Chetty R
Arch Pathol Lab Med; 2008 Aug; 132(8):1285-9. PubMed ID: 18684027
[TBL] [Abstract][Full Text] [Related]
11. Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies.
Arakelyan J; Zohrabyan D; Philip PA
Cancer; 2021 Feb; 127(3):345-353. PubMed ID: 33270905
[TBL] [Abstract][Full Text] [Related]
12. Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system.
Arnold CN; Sosnowski A; Blum HE
Ann N Y Acad Sci; 2004 Apr; 1014():218-9. PubMed ID: 15153437
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic neuroendocrine tumors: pathologic and molecular characteristics.
Shi C; Klimstra DS
Semin Diagn Pathol; 2014 Nov; 31(6):498-511. PubMed ID: 25441311
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.
Larsson C
Neuroendocrinology; 2013; 97(1):19-25. PubMed ID: 22456267
[TBL] [Abstract][Full Text] [Related]
15. New molecular aspects in the diagnosis and therapy of neuroendocrine tumors of the gastroenteropancreatic system.
Pape UF; Höcker M; Seuss U; Wiedenmann B
Recent Results Cancer Res; 2000; 153():45-60. PubMed ID: 10626288
[TBL] [Abstract][Full Text] [Related]
16. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
[TBL] [Abstract][Full Text] [Related]
17. Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system.
Arnold CN; Sosnowski A; Schmitt-Gräff A; Arnold R; Blum HE
Int J Cancer; 2007 May; 120(10):2157-64. PubMed ID: 17278096
[TBL] [Abstract][Full Text] [Related]
18. Highlights of the biology of endocrine tumours of the gut and pancreas.
Rindi G; Bordi C
Endocr Relat Cancer; 2003 Dec; 10(4):427-36. PubMed ID: 14713255
[TBL] [Abstract][Full Text] [Related]
19. Advances in the cytologic diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
Sigel CS
Cancer Cytopathol; 2018 Dec; 126(12):980-991. PubMed ID: 30485690
[TBL] [Abstract][Full Text] [Related]
20. Frequent deletion of chromosome 3 in malignant sporadic pancreatic endocrine tumors.
Guo SS; Arora C; Shimoide AT; Sawicki MP
Mol Cell Endocrinol; 2002 Apr; 190(1-2):109-14. PubMed ID: 11997184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]